Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
18-Aug-2025 | 724 | 725.25 | 687.35 | 709.1 | 35,357 | 58,06,92,196 | 3,70,227 |
19-Aug-2025 | 714.55 | 716.2 | 700.6 | 713.75 | 16,317 | 24,84,23,905.15 | 1,22,365 |
20-Aug-2025 | 719.6 | 740 | 717.3 | 730.35 | 34,411 | 64,33,05,231.7 | 3,96,522 |
21-Aug-2025 | 737 | 737.9 | 711.55 | 713.9 | 19,289 | 33,17,04,092 | 2,25,082 |
22-Aug-2025 | 714 | 722.2 | 707.95 | 716.15 | 16,635 | 20,41,88,960.05 | 1,31,113 |
25-Aug-2025 | 720.6 | 727.75 | 701.6 | 706.7 | 24,819 | 42,13,74,292.9 | 3,62,637 |
26-Aug-2025 | 705 | 718.5 | 703.25 | 707.1 | 29,429 | 85,50,55,223.25 | 7,44,684 |
28-Aug-2025 | 708 | 714 | 690.15 | 706 | 14,122 | 22,49,86,454.75 | 1,01,179 |
29-Aug-2025 | 706.5 | 718 | 693.1 | 695.05 | 21,345 | 32,28,98,571.9 | 2,06,199 |
01-Sep-2025 | 695.05 | 712.4 | 674 | 700.85 | 29,815 | 49,31,12,403 | 2,63,588 |
02-Sep-2025 | 701.95 | 708 | 695.25 | 702.65 | 9,300 | 17,35,32,266.2 | 1,24,352 |
03-Sep-2025 | 706.9 | 753.8 | 706.65 | 749.65 | 43,688 | 87,01,82,958.7 | 5,21,164 |
04-Sep-2025 | 758.7 | 789 | 751.5 | 768.75 | 53,781 | 1,09,30,41,024.2 | 5,17,225 |
05-Sep-2025 | 774.45 | 799 | 760.25 | 781.4 | 26,403 | 58,44,42,916 | 2,55,684 |
08-Sep-2025 | 781.55 | 813 | 778.2 | 787 | 26,598 | 48,34,51,979.85 | 2,59,666 |
09-Sep-2025 | 789 | 799.05 | 765 | 784.2 | 29,088 | 54,53,96,958.55 | 2,85,185 |
10-Sep-2025 | 785 | 806 | 780.7 | 798.05 | 26,973 | 38,90,10,415.5 | 2,44,098 |
11-Sep-2025 | 800.4 | 809.55 | 790.7 | 798.9 | 16,454 | 29,23,82,945.35 | 1,47,592 |
12-Sep-2025 | 798 | 806.9 | 767.55 | 770.25 | 27,572 | 52,95,34,530.15 | 3,73,387 |
15-Sep-2025 | 775 | 819.95 | 775 | 801.75 | 37,015 | 92,57,02,036.05 | 4,43,529 |
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
